Any stroke within 24 hours of surgery · patients with symptomatic or asymptomatic carotid disease
Shunting may leads to lower any stroke within 24 hours of surgery compared with no shunting (low certainty).
1 finding from 1 review
Stroke · patients with symptomatic or asymptomatic carotid disease
Shunting showed no clear difference in any stroke within 30 days of surgery compared with no shunting (low certainty).
1 finding from 1 review
Disability (primary analysis) · people with stroke recovery
1 finding from 1 review
Independent on modified Rankin score (mRS 0 to 2) (primary analysis) · people with stroke recovery
Fluoxetine showed no clear difference in independent on modified Rankin score (mRS 0 to 2) (primary analysis) compared with control at end of treatment, (high certainty).
1 finding from 1 review
Neurological deficit score · people with stroke recovery
1 finding from 1 review
no estimate extracted
30 participants
Low
Depressive symptoms · people with stroke recovery
1 finding from 1 review
Death · people with stroke recovery
Fluoxetine showed no clear difference in death compared with control at end of treatment, (moderate certainty).
1 finding from 1 review
Seizures · people with stroke recovery
Fluoxetine showed no clear difference in number of seizures compared with control at end of treatment, (moderate certainty).
1 finding from 1 review
Fracture · people with stroke recovery
Fluoxetine leads to higher bone fractures compared with control at end of treatment, (high certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · women with endometriosis, following complete surgical excision of lesions
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ pelvic pain · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ pelvic pain compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ ovarian cyst · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ ovarian cyst compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects: headache · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ headache compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ migraine · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ migraine compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ depression · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ depression compared with placebo (very low certainty).
1 finding from 1 review
Biopsy‐proven recurrence of endometriosis · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes biopsy‐proven recurrence of endometriosis compared with placebo (very low certainty).
1 finding from 1 review
Participant perception of change with treatment · adult men with premature ejaculation
SSRI probably leads to higher participant perception of change with treatment compared with placebo (moderate certainty).
1 finding from 1 review
Participant satisfaction with intercourse · adult men with premature ejaculation
SSRI probably leads to higher participant satisfaction with intercourse compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · adult men with premature ejaculation
SSRI may leads to higher study withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Perceived control over ejaculation · adult men with premature ejaculation
SSRI probably leads to higher perceived control over ejaculation compared with placebo (moderate certainty).
1 finding from 1 review